Clinical trials: De Novo Lipogenesis (DNL)
De Novo Lipogenesis (DNL), Lipid Metabolism
Implementation and Validation of an Analytical Protocol for Measuring de Novo Lipogenesis in the Liver Using Stable Isotopes
During this study, an analytical protocol for measuring hepatic de novo lipogenesis (DNL) using deuterium oxide (²H₂O) will be implemented and validated in healthy participants.
- Conditions
- De Novo Lipogenesis (DNL), Lipid Metabolism, Stable Isotope Tracing, Healthy Volunteers (HV)
- Trial name
- DNL (NCT07742423)
- Testing
- Deuterium oxide
- Where
- Belgium
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- KU Leuven
De Novo Lipogenesis (DNL)
Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis
This proof of concept- study is to measure de novo lipogenesis (DNL) non-invasively in exhaled breath in overnight-fasted humans by triggering feeding response by deuterium resolved mass spectrometry.
- Trial name
- D2OBREATH (NCT05274334)
- Testing
- Assessment of de novo lipogenesis non-invasively in exhaled breath
- Where
- Switzerland
- Volunteers
- 5 people, healthy volunteers welcome
- Sponsor
- University Children's Hospital Basel
Hepatic Steatosis, Fatty Liver
Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Nonalcoholic Fatty Liver Disease (NAFLD) is becoming the most common cause of liver disease in pediatrics, but little is known about its pathophysiology in children.
- Trial name
- DNL (NCT01725035)
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Yale University
PD Effects of GS-0976 (NDI-010976) on Fractional DNL
Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects
The primary objective of this study is to assess the pharmacodynamic (PD) effects of GS-0976 (NDI-010976) on fractional de novo lipogenesis (DNL) following a single oral dose administration in overweight and/or obese, but…
- Trial name
- NCT02876796
- Testing
- GS-0976, 1-13C acetate, Fructose solution
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Gilead Sciences